Consolidated Statement Of Profit Or Loss

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7541828

Concept 2023-01-01 to
2023-09-30
2023-01-01 to
2023-09-30
2023-01-01 to
2023-09-30
2023-07-01 to
2023-09-30
2023-01-01 to
2023-09-30
2023-01-01 to
2023-09-30
2023-01-01 to
2023-09-30
2022-07-01 to
2022-09-30
2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
837,555,000,000 JPY
257,897,000,000 JPY
225,284,000,000 JPY
821,231,000,000 JPY
Cost of sales
321,246,000,000 JPY
78,256,000,000 JPY
69,096,000,000 JPY
263,343,000,000 JPY
Gross profit
516,309,000,000 JPY
179,642,000,000 JPY
156,188,000,000 JPY
557,888,000,000 JPY
Selling, general and administrative expenses
81,821,000,000 JPY
27,541,000,000 JPY
23,780,000,000 JPY
69,724,000,000 JPY
Other expenses
JPY
2,401,000,000 JPY
Operating profit (loss)
317,598,000,000 JPY
106,688,000,000 JPY
96,887,000,000 JPY
383,835,000,000 JPY
Finance costs
19,000,000 JPY
7,000,000 JPY
15,000,000 JPY
45,000,000 JPY
Profit (loss) before tax
321,131,000,000 JPY
107,475,000,000 JPY
95,032,000,000 JPY
381,950,000,000 JPY
Income tax expense
86,865,000,000 JPY
29,903,000,000 JPY
27,235,000,000 JPY
110,000,000,000 JPY
Profit (loss)
234,266,000,000 JPY
234,266,000,000 JPY
JPY
77,573,000,000 JPY
JPY
234,266,000,000 JPY
JPY
67,797,000,000 JPY
JPY
JPY
271,950,000,000 JPY
271,950,000,000 JPY
271,950,000,000 JPY
JPY
Profit (loss) attributable to
Owners of parent
234,266,000,000 JPY
77,573,000,000 JPY
67,797,000,000 JPY
271,950,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
142.40
47.15
41.21
165.35
Diluted earnings (loss) per share
142.37
47.14
41.20
165.29

Talk to a Data Expert

Have a question? We'll get back to you promptly.